Cargando…
The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study
With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe COVID-19. This retrospective study included 122 inpatients diagnosed with COVID-19 from January 13 to February 25, 20...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909135/ https://www.ncbi.nlm.nih.gov/pubmed/33663044 http://dx.doi.org/10.1097/MD.0000000000023996 |
_version_ | 1783655864872206336 |
---|---|
author | Liu, Jiacheng Tu, Chao Zhu, Muxin Wang, Jianwen Yang, Chongtu Liu, Wei Xiong, Bin |
author_facet | Liu, Jiacheng Tu, Chao Zhu, Muxin Wang, Jianwen Yang, Chongtu Liu, Wei Xiong, Bin |
author_sort | Liu, Jiacheng |
collection | PubMed |
description | With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe COVID-19. This retrospective study included 122 inpatients diagnosed with COVID-19 from January 13 to February 25, 2020. Univariate and multivariate analysis were used to identity the risk factors, receiver operating characteristics curve (ROC) analysis was used for risk stratification. The baseline neutrophil-to-lymphocyte ratio (NLR) (OR = 1.171, 95%CI = 1.049–1.306, P = .005) and Lactate dehydrogenase (LDH) (OR = 1.007, 95%CI = 1.002–1.011, P = .004) were identified as the independent risk factors for severe COVID-19 conditions, and the NLR-LDH grading system was developed to perform risk stratification. The baseline C-reactive protein (CRP) (OR = 1.019, 95%CI = 1.004–1.306, P = .016) and B-type natriuretic peptide (BNP) (OR = 1.018, 95%CI = 1.004–1.035, P = .007) were identified as the independent predictors for disease progression of severe patients. Accordingly, The NLR-LDH grading system was a useful prognostic tool for the early detection of severe COVID-19. And in the severe patients, CRP and BNP seemed to be helpful for predicting the disease progression or death. |
format | Online Article Text |
id | pubmed-7909135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-79091352021-03-01 The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study Liu, Jiacheng Tu, Chao Zhu, Muxin Wang, Jianwen Yang, Chongtu Liu, Wei Xiong, Bin Medicine (Baltimore) 4900 With the surge of newly diagnosed and severe cases of coronavirus disease 2019 (COVID-19), the death toll is mounting, this study is aimed to explore the prognostic factors of severe COVID-19. This retrospective study included 122 inpatients diagnosed with COVID-19 from January 13 to February 25, 2020. Univariate and multivariate analysis were used to identity the risk factors, receiver operating characteristics curve (ROC) analysis was used for risk stratification. The baseline neutrophil-to-lymphocyte ratio (NLR) (OR = 1.171, 95%CI = 1.049–1.306, P = .005) and Lactate dehydrogenase (LDH) (OR = 1.007, 95%CI = 1.002–1.011, P = .004) were identified as the independent risk factors for severe COVID-19 conditions, and the NLR-LDH grading system was developed to perform risk stratification. The baseline C-reactive protein (CRP) (OR = 1.019, 95%CI = 1.004–1.306, P = .016) and B-type natriuretic peptide (BNP) (OR = 1.018, 95%CI = 1.004–1.035, P = .007) were identified as the independent predictors for disease progression of severe patients. Accordingly, The NLR-LDH grading system was a useful prognostic tool for the early detection of severe COVID-19. And in the severe patients, CRP and BNP seemed to be helpful for predicting the disease progression or death. Lippincott Williams & Wilkins 2021-02-26 /pmc/articles/PMC7909135/ /pubmed/33663044 http://dx.doi.org/10.1097/MD.0000000000023996 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | 4900 Liu, Jiacheng Tu, Chao Zhu, Muxin Wang, Jianwen Yang, Chongtu Liu, Wei Xiong, Bin The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study |
title | The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study |
title_full | The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study |
title_fullStr | The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study |
title_full_unstemmed | The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study |
title_short | The clinical course and prognostic factors of severe COVID-19 in Wuhan, China: A retrospective case-control study |
title_sort | clinical course and prognostic factors of severe covid-19 in wuhan, china: a retrospective case-control study |
topic | 4900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909135/ https://www.ncbi.nlm.nih.gov/pubmed/33663044 http://dx.doi.org/10.1097/MD.0000000000023996 |
work_keys_str_mv | AT liujiacheng theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT tuchao theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT zhumuxin theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT wangjianwen theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT yangchongtu theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT liuwei theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT xiongbin theclinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT liujiacheng clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT tuchao clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT zhumuxin clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT wangjianwen clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT yangchongtu clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT liuwei clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy AT xiongbin clinicalcourseandprognosticfactorsofseverecovid19inwuhanchinaaretrospectivecasecontrolstudy |